Journal Title：Kidney360

Kidney360 strives to be the top academic platform in the field of nephrology worldwide, with the goal of providing a wide range of knowledge resources and cutting-edge research results for nephrologists, kidney pathologists, and scientists and medical professionals interested in kidney disease. The platform covers the latest kidney disease research, diagnostic technologies and treatments, and is committed to promoting academic exchange and collaboration. By publishing high-quality research papers, review articles and clinical guidelines, we hope to provide important reference materials and data support for the global academic community and clinical practice. In addition, the platform will provide webinars, lectures and training courses to help professionals constantly update their knowledge and improve their skills to better address the challenges of kidney disease. In summary, the aim is to promote knowledge sharing and innovation in the field of nephrology by integrating the world's leading scientific research results and clinical experience, ultimately leading to more effective disease management and patient care.

《腎臟360》致力于成為全球腎臟病學領(lǐng)域的頂級學術(shù)平臺，目標是為腎臟病學家、腎臟病理學家以及對腎臟疾病有興趣的科學家和醫(yī)療專業(yè)人員提供廣泛的知識資源和前沿研究成果。該平臺涵蓋最新的腎臟疾病研究、診斷技術(shù)和治療方法，致力于推動學術(shù)交流與合作。通過發(fā)布高質(zhì)量的研究論文、綜述文章和臨床指南，希望為全球?qū)W術(shù)界和臨床實踐提供重要的參考資料和數(shù)據(jù)支持。此外，平臺還將提供在線研討會、講座和培訓課程，幫助專業(yè)人士不斷更新知識、提高技能，從而更好地應對腎臟疾病的挑戰(zhàn)。總之，旨在通過整合全球頂尖的科研成果和臨床經(jīng)驗，促進腎臟病學領(lǐng)域的知識共享與創(chuàng)新，最終實現(xiàn)更有效的疾病管理和患者照護。

Kidney360由Wolters Kluwer Health出版商出版，收稿方向涵蓋UROLOGY & NEPHROLOGY全領(lǐng)域，平均審稿速度 ，影響因子指數(shù)3.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。